Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups.
Ritzmann TA, Rogers HA, Paine SML, Storer LCD, Jacques TS, Chapman RJ, Ellison D, Donson AM, Foreman NK, Grundy RG. Ritzmann TA, et al. Pediatr Blood Cancer. 2020 Sep;67(9):e28426. doi: 10.1002/pbc.28426. Epub 2020 Jul 2. Pediatr Blood Cancer. 2020. PMID: 32614133 Clinical Trial.
Pediatric ependymomas: destined to recur?
Ritzmann TA, Kilday JP, Grundy RG. Ritzmann TA, et al. Neuro Oncol. 2021 Jun 1;23(6):874-876. doi: 10.1093/neuonc/noab066. Neuro Oncol. 2021. PMID: 33728470 Free PMC article. No abstract available.
SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium Study.
Ritzmann TA, Chapman RJ, Kilday JP, Thorp N, Modena P, Dineen RA, Macarthur D, Mallucci C, Jaspan T, Pajtler KW, Giagnacovo M, Jacques TS, Paine SML, Ellison DW, Bouffet E, Grundy RG. Ritzmann TA, et al. Neuro Oncol. 2022 Jun 1;24(6):936-948. doi: 10.1093/neuonc/noac012. Neuro Oncol. 2022. PMID: 35018471 Free PMC article. Clinical Trial.
Recurrent ACVR1 mutations in posterior fossa ependymoma.
Pratt D, Lucas CG, Selvam PP, Abdullaev Z, Ketchum C, Quezado M, Armstrong TS, Gilbert MR, Papanicolau-Sengos A, Raffeld M, Choo-Wosoba H, Chan P, Whipple N, Nasrallah M, Santi M, Ramaswamy V, Giannini C, Ritzmann TA, Grundy RG, Burford A, Jones C, Hawkins C, Venneti S, Solomon DA, Aldape K. Pratt D, et al. Among authors: ritzmann ta. Acta Neuropathol. 2022 Aug;144(2):373-376. doi: 10.1007/s00401-022-02435-2. Epub 2022 May 19. Acta Neuropathol. 2022. PMID: 35587280 No abstract available.
Toward Improved Diagnosis Accuracy and Treatment of Children, Adolescents, and Young Adults With Ependymoma: The International SIOP Ependymoma II Protocol.
Leblond P, Massimino M, English M, Ritzmann TA, Gandola L, Calaminus G, Thomas S, Pérol D, Gautier J, Grundy RG, Frappaz D. Leblond P, et al. Among authors: ritzmann ta. Front Neurol. 2022 Jun 2;13:887544. doi: 10.3389/fneur.2022.887544. eCollection 2022. Front Neurol. 2022. PMID: 35720069 Free PMC article.
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study.
Chapman RJ, Ghasemi DR, Andreiuolo F, Zschernack V, Espariat AT, Buttarelli FR, Giangaspero F, Grill J, Haberler C, Paine SML, Scott I, Jacques TS, Sill M, Pfister S, Kilday JP, Leblond P, Massimino M, Witt H, Modena P, Varlet P, Pietsch T, Grundy RG, Pajtler KW, Ritzmann TA. Chapman RJ, et al. Among authors: ritzmann ta. Neuro Oncol. 2023 Oct 3;25(10):1871-1882. doi: 10.1093/neuonc/noad055. Neuro Oncol. 2023. PMID: 36916248 Free PMC article.
Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study.
Donson AM, Bertrand KC, Riemondy KA, Gao D, Zhuang Y, Sanford B, Norris GA, Chapman RJ, Fu R, Willard N, Griesinger AM, Ribeiro de Sousa G, Amani V, Grimaldo E, Hankinson TC, Booker F, Sill M, Grundy RG, Pajtler KW, Ellison DW, Foreman NK, Ritzmann TA. Donson AM, et al. Among authors: ritzmann ta. Neuro Oncol. 2023 Oct 3;25(10):1854-1867. doi: 10.1093/neuonc/noad096. Neuro Oncol. 2023. PMID: 37246777 Free PMC article.
16 results